Evinacumab
id:
evinacumab-265-4351523
title:
Evinacumab
text:
Evinacumab, sold under the brand name Evkeeza, is a monoclonal antibody medication for the treatment of homozygous familial hypercholesterolemia (HoFH). Common side effects include nasopharyngitis (cold), influenza-like illness, dizziness, rhinorrhea, and nausea. Serious hypersensitivity (allergic) reactions have occurred in the Evkeeza clinical trials. Evinacumab binds to the angiopoietin-like protein 3 (ANGPTL3). ANGPTL3 slows the function of certain enzymes that break down fats in the body. E
brand slug:
wiki
category slug:
encyclopedia
description:
Monoclonal antibody
original url:
https://en.wikipedia.org/wiki/Evinacumab
date created:
date modified:
2024-03-03T05:41:54Z
main entity:
{"identifier":"Q19904115","url":"https://www.wikidata.org/entity/Q19904115"}
image:
fields total:
13
integrity:
14